To verify the relationship between NDRG2 and the target molecules in vivo, we also investigated the expression of NDRG2 and c-Myc, β-catenin, GLUT1, HK2, PKM2, LDHA, ASCT2, GLS1 in tissues from clinical colorectal carcinomas samples. The gene discussed is SLC2A1; the disease is colorectal carcinoma.